4.8 Article

Umap and Bismap: quantifying genome and methylome mappability

期刊

NUCLEIC ACIDS RESEARCH
卷 46, 期 20, 页码 -

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gky677

关键词

-

资金

  1. Canadian Cancer Society [703827]
  2. Ontario Institute for Cancer Research (OICR)
  3. Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-03948, RGPIN-435512-2013]
  4. University of Toronto McLaughlin Centre [MC-2015-16]
  5. Princess Margaret Cancer Foundation
  6. Canadian Cancer Society

向作者/读者索取更多资源

Short-read sequencing enables assessment of genetic and biochemical traits of individual genomic regions, such as the location of genetic variation, protein binding and chemical modifications. Every region in a genome assembly has a property called 'mappability', which measures the extent to which it can be uniquely mapped by sequence reads. In regions of lower mappability, estimates of genomic and epigenomic characteristics from sequencing assays are less reliable. These regions have increased susceptibility to spurious mapping from reads from other regions of the genome with sequencing errors or unexpected genetic variation. Bisulfite sequencing approaches used to identify DNA methylation exacerbate these problems by introducing large numbers of reads that map to multiple regions. Both to correct assumptions of uniformity in downstream analysis and to identify regions where the analysis is less reliable, it is necessary to know the mappability of both ordinary and bisulfite-converted genomes. We introduce the Umap software for identifying uniquely mappable regions of any genome. Its Bismap extension identifies mappability of the bisulfite-converted genome. A Umap and Bismap track hub for human genome assemblies GRCh37/hg19 and GRCh38/hg38, and mouse assemblies GRCm37/mm9 and GRCm38/mm10 is available at https://bismap.hoffmanlab.org for use with genome browsers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据